Cargando…
129 Urine Osmolality (Uosm) Is a Reasonable Marker of Acute (TKV) and Longer-term (eGFR) Efficacy of Vasopressin Receptor Antagonism in ADPKD: Post-hoc Analysis of TEMPO 3:4
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
Published by Elsevier Inc.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7973164/ http://dx.doi.org/10.1053/j.ajkd.2021.02.134 |
| _version_ | 1783666790066290688 |
|---|---|
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7973164 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Published by Elsevier Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-79731642021-03-19 129 Urine Osmolality (Uosm) Is a Reasonable Marker of Acute (TKV) and Longer-term (eGFR) Efficacy of Vasopressin Receptor Antagonism in ADPKD: Post-hoc Analysis of TEMPO 3:4 Am J Kidney Dis Article Published by Elsevier Inc. 2021-04 2021-03-19 /pmc/articles/PMC7973164/ http://dx.doi.org/10.1053/j.ajkd.2021.02.134 Text en Copyright © 2021 Published by Elsevier Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Article 129 Urine Osmolality (Uosm) Is a Reasonable Marker of Acute (TKV) and Longer-term (eGFR) Efficacy of Vasopressin Receptor Antagonism in ADPKD: Post-hoc Analysis of TEMPO 3:4 |
| title | 129 Urine Osmolality (Uosm) Is a Reasonable Marker of Acute (TKV) and Longer-term (eGFR) Efficacy of Vasopressin Receptor Antagonism in ADPKD: Post-hoc Analysis of TEMPO 3:4 |
| title_full | 129 Urine Osmolality (Uosm) Is a Reasonable Marker of Acute (TKV) and Longer-term (eGFR) Efficacy of Vasopressin Receptor Antagonism in ADPKD: Post-hoc Analysis of TEMPO 3:4 |
| title_fullStr | 129 Urine Osmolality (Uosm) Is a Reasonable Marker of Acute (TKV) and Longer-term (eGFR) Efficacy of Vasopressin Receptor Antagonism in ADPKD: Post-hoc Analysis of TEMPO 3:4 |
| title_full_unstemmed | 129 Urine Osmolality (Uosm) Is a Reasonable Marker of Acute (TKV) and Longer-term (eGFR) Efficacy of Vasopressin Receptor Antagonism in ADPKD: Post-hoc Analysis of TEMPO 3:4 |
| title_short | 129 Urine Osmolality (Uosm) Is a Reasonable Marker of Acute (TKV) and Longer-term (eGFR) Efficacy of Vasopressin Receptor Antagonism in ADPKD: Post-hoc Analysis of TEMPO 3:4 |
| title_sort | 129 urine osmolality (uosm) is a reasonable marker of acute (tkv) and longer-term (egfr) efficacy of vasopressin receptor antagonism in adpkd: post-hoc analysis of tempo 3:4 |
| topic | Article |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7973164/ http://dx.doi.org/10.1053/j.ajkd.2021.02.134 |